PCC is a tumor type known to have better clinical outcomes (45), however our PCC patients developed metastatic disease and ultimately died, thus suggesting that the presence of ATRX variants and perhaps a large tumor size, rather than the primary location, contributed to adverse outcomes. Here, ATRX is linked to metastatic neoplasm.